Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma

Clinical trial NCT02083211 · COMPLETED

Trial details

NCT number: NCT02083211
Sponsor: National Institute of Cancerología
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Cancer Recurrent or Persistent Palliative Treatment Monoclonal Antibody in Cervical Cancer Treatment

Start date: 2010-07-01
Primary completion: 2014-05-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.